Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VEDOLIZUMAB Cause Blood pressure increased? 1,741 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,741 reports of Blood pressure increased have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 2.4% of all adverse event reports for VEDOLIZUMAB.

1,741
Reports of Blood pressure increased with VEDOLIZUMAB
2.4%
of all VEDOLIZUMAB reports
16
Deaths
600
Hospitalizations

How Dangerous Is Blood pressure increased From VEDOLIZUMAB?

Of the 1,741 reports, 16 (0.9%) resulted in death, 600 (34.5%) required hospitalization, and 15 (0.9%) were considered life-threatening.

Is Blood pressure increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 1,741 reports have been filed with the FAERS database.

What Other Side Effects Does VEDOLIZUMAB Cause?

Off label use (21,017) Colitis ulcerative (13,455) Crohn's disease (9,759) Drug ineffective (8,424) Diarrhoea (7,493) Abdominal pain (6,401) Fatigue (5,477) Haematochezia (5,215) Frequent bowel movements (4,527) Arthralgia (4,028)

What Other Drugs Cause Blood pressure increased?

RITUXIMAB (4,185) INFLIXIMAB (2,997) CABOZANTINIB S-MALATE (2,939) OCTREOTIDE (2,799) OMALIZUMAB (2,678) TOCILIZUMAB (2,490) METHOTREXATE (2,486) NIRAPARIB (2,464) INFLIXIMAB-DYYB (2,309) AMLODIPINE (2,282)

Which VEDOLIZUMAB Alternatives Have Lower Blood pressure increased Risk?

VEDOLIZUMAB vs VELAGLUCERASE ALFA VEDOLIZUMAB vs VELCADE VEDOLIZUMAB vs VELETRI VEDOLIZUMAB vs VELIPARIB VEDOLIZUMAB vs VEMURAFENIB

Related Pages

VEDOLIZUMAB Full Profile All Blood pressure increased Reports All Drugs Causing Blood pressure increased VEDOLIZUMAB Demographics